Read, Watch or Listen

President Donald Trump announced an agreement to sell three common IVF drugs at steep discounts on TrumpRx, a direct-to-consumer site the White House plans to launch in January 2026. Prices for EMD Serono’s Gonal-F, Ovidrel and Cetrotide could drop by more than 70% from the roughly $5,000 per cycle patients now pay, he said. The deal includes tariff reprieves tied to U.S. manufacturing and research, and Pfizer and AstraZeneca struck similar arrangements. Trump urged employers to add optional IVF coverage, but no mandate is planned—falling short of his earlier pledge of universal free IVF.

Prepared by Lauren Mitchell and reviewed by editorial team.